Toby Talbot
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
- Cutaneous Melanoma Detection and Management 2
- CAR-T cell therapy research 2
-
- Occupational and environmental lung diseases 1
- Lung Cancer Diagnosis and Treatment 1
- Co-authors
- Timothy M.M. Farley (1 shared paper)Leonie Eastlake (1 shared paper)Michael Rowe (1 shared paper)K. Balachandran (1 shared paper)Carles Escriu (1 shared paper)Rosario García Campelo (1 shared paper)Solange Peters (1 shared paper)Ellen M. Ross (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Clinical Oncology (2 papers)The Lancet (1 paper)Journal of Clinical Oncology (1 paper)Lung Cancer (1 paper)
- Partner nations
- United KingdomSwitzerlandItaly
In The Last Decade
Toby Talbot
14 papers receiving 594 citations
Peers
Comparison fields: 5 of 47
- Oncology 397
- Pulmonary and Respiratory Medicine 151
- Immunology 78
- Molecular Biology 204
- Cancer Research 34
Countries citing papers authored by Toby Talbot
This map shows the geographic impact of Toby Talbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby Talbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby Talbot more than expected).
Fields of papers citing papers by Toby Talbot
This network shows the impact of papers produced by Toby Talbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby Talbot. The network helps show where Toby Talbot may publish in the future.
Co-authors
The 25 scholars most cited alongside Toby Talbot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 181 | |
| 2 | 2015 | 114 | |
| 3 | 2023 | 109 | |
| 4 | 2023 | 71 | |
| 5 | 2018 | 58 | |
| 6 | 2015 | 49 | |
| 7 | 2021 | 8 | |
| 8 | 2023 | 5 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2017 | 3 | |
| 12 | 2025 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2026 | 1 | |
| 15 | 2025 | 0 |
About Toby Talbot
Toby Talbot is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Ophthalmology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 608 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Cutaneous Melanoma Detection and Management (2 papers), CAR-T cell therapy research (2 papers), Melanoma and MAPK Pathways (1 paper), Occupational and environmental lung diseases (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), Immunotherapy and Immune Responses (1 paper) and Retinal and Macular Surgery (1 paper). The work is most often cited by research in Oncology (397 citations), Pulmonary and Respiratory Medicine (151 citations), Immunology (78 citations), Molecular Biology (204 citations) and Cancer Research (34 citations). Toby Talbot has collaborated with scholars based in United Kingdom, Switzerland and Italy. Frequent co-authors include Timothy M.M. Farley, Leonie Eastlake, Michael Rowe, K. Balachandran, Carles Escriu, Rosario García Campelo, Solange Peters, Ellen M. Ross, Raffaele Califano and Anne S. Tsao. Their work appears in journals such as Annals of Oncology, Clinical Oncology, The Lancet, Journal of Clinical Oncology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.